88IV - PR Newswire Asia's news - Infectious Disease Control

< Previous page

| Title only | Print

< Previous page

SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention SK bioscience is jointly investing with the RIGHT Foundation to drive process development that enhances ... 2026-06-09T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Duke-NUS awarded 2 million EU grant to help Asia detect outbreaks earlier through wastewater surveillance EU-funded project will help countries build early-warning systems to spot infectious disease threats before clinical cases surge ... 2026-06-09T Education Health Care/Hospital Higher Education Infectious Disease Control
Ebola disease in Democratic Republic of Congo: MSF scales up response to a rapidly evolving outbreak HONG KONG , June 1, 2026 /PRNewswire/ -- In eastern Democratic Republic of Congo (DRC), people have been living through insecurity and with an under-resourced health system for years. The Ebola disease ... 2026-06-01T Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
WuXi Vaccines' Drug Substance Facility Receives Brazil ANVISA GMP Certification for Dengue Vaccine Manufacturing SUZHOU, China , May 26, 2026 /PRNewswire/ -- WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced today ... 2026-05-26T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Wincomm Secures Computex Best Choice Award for Three Consecutive Years (2024-2026), Leading the Future of AI-Powered Medical Solutions HSINCHU, May 21, 2026 /PRNewswire/ -- Wincomm Corporation, a global leader in medical and industrial computing, is proud to announce it has achieved a prestigious milestone by winning the Computex Best ... 2026-05-21T Computer Hardware Computer/Electronics Health Care/Hospital Infectious Disease Control
MVC's ENVACGEN® is Granted First Enterovirus A71 Vaccine Marketing Authorization in Vietnam; Joins Forces with Substipharm Biologics to Expand Southeast Asian Market TAIPEI and GENEVA , March 18, 2026 /PRNewswire/ -- Medigen Vaccine Biologics Corp. (MVC) and Substipharm Biologics announced on March 17 that ENVACGEN®, an Enterovirus 71 (EV-A71) vaccine, ... 2026-03-18T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved